序号 |
标题 |
次数 |
作者 |
发布时间 |
79291 |
基于CRISPR/Cas9的基因敲入(KI) |
259 |
axc |
2024-12-17 |
79292 |
基于CRISPR/Cas9的基因敲除(KO) |
239 |
axc |
2024-12-17 |
79293 |
Ald-Ph-PEG4-bis-PEG3-methyltetrazine |
157 |
WYQ |
2024-12-16 |
79294 |
Ald-Ph-amido-PEG3-C1-Boc(CAS: 1007215-94-2) |
135 |
WYQ |
2024-12-16 |
79295 |
p-SCN-Bn-DOTA,127985-74-4 |
112 |
h |
2024-12-16 |
79296 |
Fmoc-Phe-Lys(Trt)-PAB-PNP(CAS: 1116086-09-9) |
232 |
WYQ |
2024-12-16 |
79297 |
DTPA-tetra(t-Bu ester),174267-71-1 |
147 |
h |
2024-12-16 |
79298 |
DOTA-tris(t-Bu ester),137076-54-1 |
119 |
h |
2024-12-16 |
79299 |
Fmoc-Phe-Lys(Trt)-PAB-PNP(CAS: 1116086-09-9) |
129 |
WYQ |
2024-12-16 |
79300 |
DOTA-folate,大环配合物修饰叶酸 |
102 |
h |
2024-12-16 |
79301 |
DOTA-(MeAm)4,CAS号:219143-29-0 |
111 |
h |
2024-12-16 |
79302 |
DOTA-mono-NHS tris(t-Bu ester) |
114 |
h |
2024-12-16 |
79303 |
NHPI-PEG4-C2-NHS ester(CAS:1415328-95-8) |
137 |
WYQ |
2024-12-16 |
79304 |
DOTA-Crgd,双功能螯合剂DOTA-多肽 |
105 |
h |
2024-12-16 |
79305 |
NH2-PEG4-Lys(Boc)-NH-(m-PEG24) |
150 |
WYQ |
2024-12-16 |
79306 |
Bromoacetamido-PEG-DOTA,溴乙酰胺-PEG-DOTA |
75 |
h |
2024-12-16 |
79307 |
DOTA-Me-tetrazine,DOTA-MeTz,大环配体金属螯合剂 |
105 |
h |
2024-12-16 |
79308 |
N3-PEG4-C2-Pfp ester(CAS:1353012-00-6) |
132 |
WYQ |
2024-12-16 |
79309 |
cas:2028284-71-9,m-PEG6-(CH2)6-phosphonic acid,甲基-六聚乙二醇-膦酸 |
94 |
kx |
2024-12-16 |
79310 |
DOTA-YTA2,DOTA偶联细胞穿膜肽YTA2 |
150 |
h |
2024-12-16 |
79311 |
HS-(CH2)11-NMe3+ Cl- , 巯基-十一烷-NMe3+ Cl- |
94 |
kx |
2024-12-16 |
79312 |
DOTA-[Tyr3]-Octreotide,DOTA-(酪氨酸3)-奥曲肽,CAS号:204318-14-9 |
104 |
h |
2024-12-16 |
79313 |
HS-(CH2)6-EG8-Biotin , 巯基-六烷烃-八聚乙二醇-生物素 |
92 |
kx |
2024-12-16 |
79314 |
大环配体化合物Tm-p-SCN-Bn-DOTA,CAS:2126179-32-4 |
163 |
h |
2024-12-16 |
79315 |
Mal-amido-PEG2-NHS ester(CAS:955094-26-5) |
120 |
WYQ |
2024-12-16 |
79316 |
DOTA-E[c(RGDfK)2],DOTA标记的双c(RGDfK)环肽 |
114 |
h |
2024-12-16 |
79317 |
HS-(CH2)8-EG5-OCH2-COOH , 巯基-八烷烃-五聚乙二醇-OCH2-羧基 |
131 |
kx |
2024-12-16 |
79318 |
DOTA-RGD,DOTA-cyclo(Arg-Gly-Asp-DTyr-Lys) |
102 |
h |
2024-12-16 |
79319 |
二肽DOTA-Lys-Cys,DOTA-Lys-Cys-Acid氨基酸衍生物肽 |
121 |
h |
2024-12-16 |
79320 |
Fmoc-NH-Azide-PEG4-L-Lysine-PFP ester |
112 |
WYQ |
2024-12-16 |
79321 |
HS-(CH2)6-EG12-NH3+ Cl- ,巯基-六烷烃-十二聚乙二醇-NH3+ Cl- |
116 |
kx |
2024-12-16 |
79322 |
DBCO-PEG4-acetic-Val-Cit-PAB |
107 |
WYQ |
2024-12-16 |
79323 |
Fmoc-L-Phe(4-CH2-PO3Et2)-OH(CAS号:160253-13-4) |
152 |
WYQ |
2024-12-16 |
79324 |
HS-(CH2)11-EG6-OH ,巯基-11烷烃-六聚乙二醇-羟基 |
110 |
kx |
2024-12-16 |
79325 |
Fmoc-L-Phe(4-CH2-OtBu)-OH(CAS号:204384-68-9) |
129 |
WYQ |
2024-12-16 |
79326 |
Au-S-Polymer-8HQ ,金-硫-聚合物-8HQ |
147 |
kx |
2024-12-16 |
79327 |
Au-S-(CH2)11-N(CH3)3+Cl- ,金-硫-11烷烃-N(CH3)3+氯- |
171 |
kx |
2024-12-16 |
79328 |
Biotin-NH-CH2-CH2-NH-Cysteine*TFA(CAS号:288144-42-3) |
93 |
WYQ |
2024-12-16 |
79329 |
DOTA-PEG4-Methyl tetrazine;甲基四嗪聚乙二醇大环化合物 |
156 |
h |
2024-12-16 |
79330 |
Fmoc-NH-(CH2)17-COOH(CAS号:1199580-37-4) |
141 |
WYQ |
2024-12-16 |
79331 |
DOTA-PEG4-NH2;DOTA-四聚乙二醇-氨基 |
108 |
h |
2024-12-16 |
79332 |
HS-C11-EG4-Carboxybetaine, HS-C11-EG4羧基甜菜碱 |
90 |
kx |
2024-12-16 |
79333 |
DOTA-CH2-Alkynyl(HCl salt)螯合剂标记修饰物 |
96 |
h |
2024-12-16 |
79334 |
Boc-NH-(CH2)17-COOH(CAS号:2389064-45-1) |
131 |
WYQ |
2024-12-16 |
79335 |
DOTA-peg-Angiopep;大环配体-聚乙二醇-八肽衍生物 |
98 |
h |
2024-12-16 |